Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02873273 · ClinicalTrials.gov registry record · Phase 1
Study of a Steroid Delivery System for Pain Relief Treatment in Patients With Knee Osteoarthritis
A Phase 1 study of Osteoarthritis, Knee, sponsored by Mark Figgie.
- Completed
- Registry status
- Phase 1
- Development phase
- 6
- Enrollment target
- 1
- Study location
NCT02873273 is a Phase 1 study of Osteoarthritis, Knee that has completed, run by Mark Figgie. The registered enrollment target is 6 participants, below the 580-participant average among 91 other Osteoarthritis, Knee trials with a reported enrollment target (99% lower). The trial reports 1 study location across 1 state.
The verdict
NCT02873273, a Phase 1 study of Osteoarthritis, Knee, has completed, sponsored by Mark Figgie.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 6 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to determine whether a longer duration, controlled, sustained release dexamethasone delivery system would be more effective in helping patients with osteoarthritis reduce their pain, remain functional, and delay their need for knee replacement.
Conditions Studied
Interventions
- DRUG Dexamethasone
Study Locations (1)
New York
- Hospital for Special Surgery - New York
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 6 participants |
| Start Date | 2016-10-14 |
| Est. Completion | 2017-09-21 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02873273
The ClinicalTrials.gov registry entry for NCT02873273 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 6 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 580-participant average among 91 other Osteoarthritis, Knee trials with a reported enrollment target (99% lower). The listed sponsor is Mark Figgie, which has 1 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Osteoarthritis, Knee appearing as the primary indexed condition, and to 1 intervention - of which Dexamethasone is the first listed.
NCT02873273 reports 1 study location spanning 1 distinct geographic area - top geographies include New York.
Frequently Asked Questions
What is clinical trial NCT02873273 about?
NCT02873273 is a clinical study titled "Study of a Steroid Delivery System for Pain Relief Treatment in Patients With Knee Osteoarthritis". The purpose of this study is to determine whether a longer duration, controlled, sustained release dexamethasone delivery system would be more effective in helping patients with osteoarthritis reduce their pain, remain functional, and delay their need for knee replacement.
What is the current status of trial NCT02873273?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 6 participants. The study started on 2016-10-14. Estimated completion is 2017-09-21.
What conditions does trial NCT02873273 study?
This clinical trial studies the following conditions: Osteoarthritis, Knee.
What interventions are being tested in trial NCT02873273?
The interventions under investigation include: Dexamethasone (DRUG).
Who is sponsoring clinical trial NCT02873273?
This trial is sponsored by Mark Figgie, which has 1 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02873273 being conducted?
This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Osteoarthritis, Knee
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
A Hip Flexion Feedback System for Exercise Monitoring in Individuals With Osteoarthritis and Obesity
RECRUITING · Phase 1
-
CBD for Knee Osteoarthritis
RECRUITING · Phase 1
-
Oral Steroid Taper After Total Knee Arthroplasty
RECRUITING · Phase 1
-
Safety and Pharmacodynamics of GNSC-001 Intra-articular Injection for Knee Osteoarthritis
ACTIVE NOT RECRUITING · Phase 1
-
Prospective Evaluation of PRP and BMC Treatment to Accelerate Healing After ACL Reconstruction
ACTIVE NOT RECRUITING · Phase 1
-
Use of Senolytic and Anti-Fibrotic Agents to Improve the Beneficial Effect of Bone Marrow Stem Cells for Osteoarthritis
ACTIVE NOT RECRUITING · Phase 1
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.